T. Rowe Price Associates’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $401K | Buy |
|
|||||
|
2025
Q1 | $140K | Buy |
|
|||||
|
2024
Q4 | $164K | Sell |
|
|||||
|
2024
Q3 | $195K | Buy |
|
|||||
|
2024
Q2 | $144K | Buy |
|
|||||
|
2024
Q1 | $337K | Buy |
|
|||||
|
2023
Q4 | $276K | Buy |
|
|||||
|
2023
Q3 | $243K | Buy |
|
|||||
|
2023
Q2 | $317K | Buy |
|
|||||
|
2023
Q1 | $223K | Buy |
|
|||||
|
2022
Q4 | $286K | Sell |
|
|||||
|
2022
Q3 | $525K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $220K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $41.3M | Buy |
|